Presentations – Oncopeptides

Investors & mediaPresentations

Presentation at 23rd Congress of The European Hematology Association (EHA)

June 15, 2018

The updated phase II-data show a clinical data set with an Overall Response Rate (ORR) of 32.1% and a Clinical Benefit Rate (CBR) of 39.3% with Ygalo® in relapsed/refractory multiple myeloma patients ...

Jefferies Health Care conference, New York – Presentation

June 7, 2018

Oncopeptides CEO Jakob Lindberg held a presentation at Jefferies Healthcare Conference in New York June 7.

Jakob Lindberg, CEO, is interviewed in Di tv

May 17, 2018

Oncopeptides CEO Jakob Lindberg interviewed at DI Börsmorgon (Di tv) about the Q1 Interim report and the future, May 17, 2018.

Carnegie Healthcare Seminar 2018 – presentation

March 14, 2018

Oncopeptides CEO Jakob Lindberg held a presentation at Carnegie Healthcare Seminar on March 14.

SCF Life Science Seminarium – presentation

March 7, 2018

Oncopeptides CEO Jakob Lindberg held a presentation at Stockholm Corporate Finance Live Science Seminarium March 7. Click here to view the recorded presentation.

ABGSC Orphan Drug Day 2018 – Presentation

February 22, 2018

Oncopeptides presentation at the ABG Office in Stockholm, Sweden

JP Morgan, San Francisco – Presentation

January 13, 2018

January 8-10, 2018

DNB Nordic Healthcare Conference 2017 – Oslo

December 14, 2017

Oncopeptides' presentation at DNB in Oslo, 14 December

ASH summary Webcast

December 13, 2017

Oncopeptides had a press conference on December 13. The conference was recorded. Click here to view the Webcast.

59th ASH Annual Meeting & Exposition – Posters

December 9, 2017

Horizon Poster (9 Dec 2017) and O-12-M1 Poster (10 Dec 2017)

Carnegie Healthcare Day in New York – presentation

December 6, 2017

Oncopeptides presentation at Carnegie, New York, 5 December 2017.

Lunch at ABG – presentation

November 15, 2017

Presentation at ABG

American Society of Hematology (ASH) – Abstract

November 1, 2017

Pareto Securities Healthcare conference 2017 – Presentation

September 7, 2017

Annual General Meeting 2017 – Presentation

May 18, 2017

DNB SME Conference 2017

April 5, 2017

Carnegie Health Care Seminar

March 16, 2017

Redeye – Fight cancer-event

March 10, 2017

Interim Report Q2 2018

Oncopeptides Interim Report Q2 2018 was published on July 13, 2018.

Read the report

Calendar

Interim Report Q3 2018 October 26, 2018
Year-end report 2018 February 22, 2019

Welcome to Oncopeptides AB’s (publ) website. In order to optimize your use of our website we use cookies. A cookie is a text file stored on your computer. If you want more information about what a cookie is, what the purpose of the cookie is and how you can block or delete cookies, please read the our cookie guidelines “About cookies”. By continuing, you agree to our use of cookies.

Close